Selective activation of the K+ATP channel is a mechanism by which sudden death is produced by low-energy chest-wall impact (commotio cordis)

被引:97
作者
Link, MS
Wang, PJ
VanderBrink, BA
Avelar, E
Pandian, NG
Maron, BJ
Estes, NAM
机构
[1] Tufts Univ, Sch Med, New England Med Ctr, Cardiac Arrhythmia Serv, Boston, MA 02111 USA
[2] Minneapolis Heart Inst Fdn, Cardiovasc Res Div, Minneapolis, MN USA
关键词
ventricular fibrillation; death; sudden; chest trauma; sports;
D O I
10.1161/01.CIR.100.4.413
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Sudden death due to relatively innocent chest-wall impact has been described in young individuals (commotio cordis). In our previously reported swine model of commotio cordis, ventricular fibrillation (with T-wave strikes) and ST-segment elevation (with QRS strikes) were produced by 30-mph baseball impacts to the precordium. Because activation of the K-ATP(+) channel has been implicated in the pathogenesis of ST elevation and ventricular fibrillation in myocardial ischemia, we hypothesized that this channel could be responsible for the electrophysiologic findings in our experimental model and in victims of commotio cordis. Methods and Results-In the initial experiment, 6 juvenile swine were given 0.5 mg/kg IV glibenclamide, a selective inhibitor of the K-ATP(+) channel, and chest impact was given on the QRS. The results of these strikes were compared with animals in which no glibenclamide was given. In the second phase, 20 swine were randomized to receive glibenclamide or a control vehicle (in a double-blind fashion), with chest impact delivered just before the T-wave peak. With QRS impacts, the maximal ST elevation was significantly less in those animals given glibenclamide (0.16+/-0.10 mV) than in controls (0.35+/-0.20 mV; P=0.004), With T-wave impacts, the animals that received glibenclamide had significantly fewer occurrences of ventricular fibrillation (1 episode in 27 impacts; 4%) than controls (6 episodes in 18 impacts; 33%; P=0.01). Conclusions-In this experimental model of commotio cordis, blockade of the KC, channel reduced the incidence of ventricular fibrillation and the magnitude of ST-segment elevation. Therefore, selective K-ATP(+) channel activation may be a pivotal mechanism in sudden death resulting from low-energy chest-wall trauma in young people during sporting activities.
引用
收藏
页码:413 / 418
页数:6
相关论文
共 27 条
[1]   COMMOTIO CORDIS - THE SINGLE, MOST COMMON CAUSE OF TRAUMATIC DEATH IN YOUTH BASEBALL [J].
ABRUNZO, TJ .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1991, 145 (11) :1279-1282
[2]  
Adler P, 1996, YOUTH BASEBALL PROTE, P1
[3]   A view of SUR/KIR6.X, KATP channels [J].
Babenko, AP ;
Aguilar-Bryan, L ;
Bryan, J .
ANNUAL REVIEW OF PHYSIOLOGY, 1998, 60 :667-687
[4]   K-ATP channel modulators increase survival rate during coronary occlusion-reperfusion in anaesthetized rats [J].
Baczko, I ;
Lepran, I ;
Papp, JG .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 324 (01) :77-83
[5]   EFFECTS OF GLYBURIDE ON ISCHEMIA-INDUCED CHANGES IN EXTRACELLULAR POTASSIUM AND LOCAL MYOCARDIAL ACTIVATION - A POTENTIAL NEW APPROACH TO THE MANAGEMENT OF ISCHEMIA-INDUCED MALIGNANT VENTRICULAR ARRHYTHMIAS [J].
BEKHEIT, SS ;
RESTIVO, M ;
BOUTJDIR, M ;
HENKIN, R ;
GOOYANDEH, K ;
ASSADI, M ;
KHATIB, S ;
GOUGH, WB ;
ELSHERIF, N .
AMERICAN HEART JOURNAL, 1990, 119 (05) :1025-1033
[6]   THE EFFECTS OF THE ATP-DEPENDENT POTASSIUM CHANNEL ANTAGONIST, GLYBURIDE, ON CORONARY BLOOD-FLOW AND SUSCEPTIBILITY TO VENTRICULAR-FIBRILLATION IN UNANESTHETIZED DOGS [J].
BILLMAN, GE ;
AVENDANO, CE ;
HALLIWILL, JR ;
BURROUGHS, JM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 (02) :197-204
[7]   ROLE OF ATP-SENSITIVE POTASSIUM CHANNEL IN EXTRACELLULAR POTASSIUM ACCUMULATION AND CARDIAC-ARRHYTHMIAS DURING MYOCARDIAL-ISCHEMIA [J].
BILLMAN, GE .
CARDIOVASCULAR RESEARCH, 1994, 28 (06) :762-769
[8]   Fatal impact - Concussion of the heart [J].
Curfman, GD .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (25) :1841-1843
[9]  
Dickman Gerald L, 1978, Phys Sportsmed, V6, P85, DOI 10.1080/00913847.1978.11948393
[10]  
FINDLAY I, 1992, J PHARMACOL EXP THER, V261, P540